CBDH.F Stock Overview
A health and wellness supplement company, offers CBD and probiotic products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Hempfusion Wellness Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.001 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | -99.00% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | -100.00% |
5 Year Change | n/a |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
CBDH.F | US Personal Products | US Market | |
---|---|---|---|
7D | 0% | 4.3% | 2.2% |
1Y | 0% | -12.0% | 31.6% |
Return vs Industry: CBDH.F exceeded the US Personal Products industry which returned -12% over the past year.
Return vs Market: CBDH.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
CBDH.F volatility | |
---|---|
CBDH.F Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 8.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CBDH.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CBDH.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Jason Mitchell | www.hempfusion.com |
Hempfusion Wellness Inc., a health and wellness supplement company, offers CBD and probiotic products in the United States. It provides tinctures, capsules, gummies, and topical creams and gel products. The company offers its products under the HempFusion, Sagely Naturals, and Apothecanna brands in approximately 18,000 retail stores in the United States and internationally.
Hempfusion Wellness Inc. Fundamentals Summary
CBDH.F fundamental statistics | |
---|---|
Market cap | US$162.00 |
Earnings (TTM) | -US$31.70m |
Revenue (TTM) | US$6.26m |
0.0x
P/S Ratio0.0x
P/E RatioIs CBDH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CBDH.F income statement (TTM) | |
---|---|
Revenue | US$6.26m |
Cost of Revenue | US$4.57m |
Gross Profit | US$1.69m |
Other Expenses | US$33.39m |
Earnings | -US$31.70m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CBDH.F perform over the long term?
See historical performance and comparison